Tandem Diabetes Care Inc (TNDM)

Debt-to-equity ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 285,035 284,580 284,128 283,679 283,232 282,787 282,345 281,905 281,467 281,032 280,599 280,168 202,984 199,120 195,344 — 0 — — —
Total stockholders’ equity US$ in thousands 313,632 314,000 329,234 338,753 439,947 421,822 449,584 437,382 433,112 389,654 346,085 313,414 366,305 326,544 267,704 207,176 194,979 166,994 145,345 120,962
Debt-to-equity ratio 0.91 0.91 0.86 0.84 0.64 0.67 0.63 0.64 0.65 0.72 0.81 0.89 0.55 0.61 0.73 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $285,035K ÷ $313,632K
= 0.91

The debt-to-equity ratio for Tandem Diabetes Care Inc has shown a varying trend over the past eight quarters. In the most recent quarter, Q4 2023, the ratio stood at 0.91, which was consistent with the previous quarter, Q3 2023. This indicates that the company's total debt was approximately equal to its total equity during this period.

Looking further back, we observe an increase in the debt-to-equity ratio from Q1 2023 to Q4 2022, reaching a peak of 0.64 in Q4 2022. This suggests an increase in the company's debt relative to its equity during that period. Subsequently, the ratio remained relatively stable around the 0.6 range for the preceding quarters of 2022.

Overall, the trend in Tandem Diabetes Care Inc's debt-to-equity ratio indicates fluctuations in the capital structure of the company over the past two years. Investors and stakeholders may want to monitor this ratio closely to assess the company's leverage and financial risk levels.